Do Clinical Trial Service Providers Need a Co-founder Agreement in Australia?

If you are building a clinical trial service provider with another founder, a handshake is not enough. Founders in this space often make the same early mistakes: they split equity casually without tying it to actual work, assume intellectual property automatically belongs to the company, or rely on verbal promises about who will manage sponsor relationships, compliance, or fundraising. Those shortcuts can become expensive once the business starts negotiating with sponsors, research sites, software vendors, or investors.

A well-drafted co-founder agreement helps you sort out ownership, decision-making, confidentiality, restraint issues, and what happens if one founder leaves. For Australian clinical trial service providers, those questions matter even more because the business may handle sensitive information, specialist know-how, regulated workflows, and long sales cycles. Here, we explain when a co-founder agreement makes sense, what it should cover, and the legal issues founders should check before they sign.

Overview

A co-founder agreement is usually a smart move for a clinical trial service provider in Australia, especially where founders bring different assets, such as industry contacts, software, protocols, business development capability, or capital. It creates a clear record of who owns what, who does what, and how disputes or exits will be handled before those issues become urgent.

• Confirm who the founders are contracting with, each other personally, or the company.
• Set out equity ownership, vesting, dilution rules, and what happens if a founder stops contributing.
• Deal with intellectual property, including software, databases, templates, branding, and pre-existing know-how.
• Allocate decision-making power for major contracts, hiring, budgets, borrowing, and investor negotiations.
• Cover confidentiality, privacy responsibilities, and handling of commercially sensitive trial information.
• Include exit rules, restraint clauses where appropriate, and a process for deadlocks or disputes.

What Co-founder Agreement for Clinical Trial Service Provider Means For Australian Businesses

A co-founder agreement is the practical rulebook for your founder relationship. It is not just a formality for investors, it is the document that can stop a commercial disagreement from turning into a business-ending dispute.

Clinical trial service providers often sit in a specialised part of the market. You might support sponsors, contract research organisations, principal investigators, trial sites, or health tech partners. One founder may bring scientific credibility and operational knowledge, while another brings software, commercial strategy, or funding. If those contributions are not documented properly, disputes tend to surface when the business wins its first major contract, seeks investment, or one founder wants out.

Why this matters more in the clinical trials sector

The business model usually depends on trust, expertise, systems, and relationships. In many cases, the main assets are not physical. They are the study management processes, protocol templates, participant engagement tools, dashboards, standard operating procedures, client lists, and regulatory know-how built by the founders.

That creates a simple legal question with big consequences: who owns those assets? If a founder created software before the company existed, or has long-standing sponsor relationships, or developed trial documentation in a previous role, the agreement needs to be very clear about what is contributed, licensed, excluded, or assigned.

Is a co-founder agreement legally required?

No, Australian law does not generally require founders to have a separate co-founder agreement before they work together. But not having one is risky.

Without a written agreement, you may be left trying to piece together emails, texts, draft cap tables, invoices, and verbal conversations to work out ownership and responsibilities. That is exactly where founders often get caught, especially before they sign supplier contracts, before they accept the provider's standard terms, or before they rely on a verbal promise about equity.

How it fits with company documents

A co-founder agreement does not replace your company constitution, shareholders agreement, employment agreements, contractor agreements, or IP assignment documents. It usually sits alongside them.

For example, if you operate through an Australian company, you may also need:

• a shareholders agreement dealing with share ownership and shareholder rights at company level
• employment or contractor agreements for founder work performed day to day
• IP assignment clauses to ensure the company owns key business assets
• confidentiality terms covering clinical, operational, and commercial information
• privacy documentation, such as a privacy notice, if the business handles personal information

The right structure depends on how your business is set up, whether founders are already shareholders, and whether the company has external investors.

Typical founder scenarios

A co-founder agreement is particularly useful where:

• one founder is contributing cash and another is contributing labour or expertise
• one founder is keeping their current role part time while another works full time
• the business is building software or data systems for trial administration
• founders are bringing in pre-existing templates, databases, branding, or contacts
• the business expects to raise capital or grant options later
• there is any uncertainty about who can make decisions before the board is fully formed

If any of those apply, a written founder arrangement is usually worth doing before you sign major commercial contracts.

Legal Issues To Check Before You Sign

The main legal issues are ownership, control, confidentiality, and exits. If those four areas are vague, the agreement is not doing enough.

1. Equity split and vesting

An equal split sounds fair, but it often causes trouble if founders are contributing very different levels of time, capital, or expertise. Before you sign, make sure the equity arrangement reflects the commercial reality, not just optimism at the start.

You should usually address:

• how many shares or what percentage each founder will hold
• whether those shares vest over time or against milestones
• what happens if a founder leaves early
• whether unvested shares can be bought back, and at what price
• how future capital raisings or option pools may dilute each founder

Vesting is especially important in founder-led service businesses. If one person leaves after six months but keeps a large equity stake, that can damage investor confidence and create resentment for the team still doing the work.

2. Roles, responsibilities and authority

A founder agreement should say who is responsible for what. Titles alone are not enough.

For a clinical trial service provider, it helps to divide operational authority clearly. One founder may lead site operations, protocol delivery, or sponsor account management. Another may control product, data systems, finance, or growth. The agreement should also say which decisions require both founders to approve, such as entering high-value service agreements, borrowing money, hiring senior staff, or changing pricing.

This matters before you sign a contract with a sponsor or platform provider. If one founder assumes they can bind the business alone and the other disputes that authority, the legal and commercial fallout can be messy.

3. Intellectual property ownership

IP is often the most valuable asset in this type of business. If ownership is unclear, the business can lose control over core tools and know-how.

Your agreement should deal with:

• pre-existing IP each founder already owns before joining forces
• new IP created after the business starts, including software, workflows, templates, training materials, branding, and internal systems
• whether pre-existing IP is assigned to the company, licensed to it, or kept outside the business
• moral rights consents where relevant for copyright material
• obligations to sign further documents if ownership needs to be formalised later

Founders should be especially careful where they previously worked for a university, health service, sponsor, CRO, or another startup. Material created in an earlier role may already be subject to other contractual obligations. Before you rely on a verbal promise that a founder can bring across templates or technology, check the underlying contracts.

4. Confidentiality and privacy

A standard confidentiality clause may not be enough if the business handles sensitive trial-related information. The agreement should reflect the actual information flows in the business.

Clinical trial service providers may deal with:

• commercially sensitive sponsor information
• protocol and trial design details
• site performance information
• participant-related data or personal information
• pricing, budgets, and vendor arrangements

A founder agreement should set expectations about how information is used, stored, disclosed, and returned if a founder exits. It should also line up with the business's privacy obligations, data protection requirements, and any confidentiality commitments given to clients or partners. Privacy law obligations depend on the nature of the information handled and the structure of the business, so tailored advice is often worthwhile.

5. Restraints and non-compete issues

Reasonable restraint clauses can help protect the business if a founder leaves and tries to take clients, staff, or confidential material. But restraints must be drafted carefully to improve their enforceability.

In practice, founders often want clauses covering:

• not soliciting key clients or sponsor contacts for a period after exit
• not poaching staff or contractors
• not using confidential templates, SOPs, or systems in a competing venture

Australian courts do not automatically enforce broad restraints. The scope, duration, and geographic reach need to be reasonable and tied to a legitimate business interest.

6. Decision-making and deadlock

If founders hold equal shares, deadlock is a real risk. The agreement should include a mechanism for resolving major disputes before they freeze the business.

That could involve escalation steps such as:

• a formal meeting process
• referral to an agreed adviser or mediator
• board casting vote arrangements, if suitable
• buy-sell processes in serious deadlock situations

This is particularly important where the business is negotiating regulated service contracts or trying to respond quickly to a sponsor requirement. A stalemate at the wrong time can cost the business a deal.

7. Exit events and founder departures

The agreement should plan for a founder leaving while relations are still good. That is much easier than trying to negotiate an exit during a dispute.

Check what happens if a founder:

• resigns
• stops meeting agreed performance commitments
• becomes ill or unavailable for an extended period
• is dismissed from an operational role
• wants to sell their shares
• dies or becomes incapacitated

You should also be clear on valuation mechanics, transfer restrictions, notice periods, and whether remaining founders have a first right to buy the departing founder's shares.

8. Alignment with other contracts

Your founder agreement should not contradict your other legal documents. Inconsistencies create avoidable confusion and sometimes invalid assumptions.

Before you sign, compare it against:

• the company constitution
• any shareholders agreement
• employment and contractor agreements
• existing service agreements with clients or suppliers
• privacy documents and internal policies

If the founder agreement says one thing about ownership or authority, and another document says the opposite, the business can end up in a dispute when the pressure is on.

Common Mistakes With Co-founder Agreement for Clinical Trial Service Provider

The most common mistake is waiting until after the first disagreement. A founder agreement works best when everyone is still aligned and prepared to be specific.

Assuming trust is enough

Many founders know each other from the industry and feel awkward about formal paperwork. Trust is helpful, but memory changes once money, equity, and workload become uneven.

A written agreement protects the relationship because it reduces room for misunderstanding.

Using a generic template that ignores the business model

A basic online template rarely deals properly with sector-specific issues. A clinical trial service provider may rely on systems, proprietary workflows, and strict confidentiality expectations that a generic founder document does not address.

This is where founders often get caught before they accept the provider's standard terms from a major client or before they pitch to investors who ask who owns the core platform or operating method.

Leaving IP unclear

Founders often assume that if they paid for development, the company owns the result. That is not always right.

If a founder, contractor, or third party created software, documents, or branding without a proper assignment, ownership can remain with the creator. That problem tends to surface during due diligence, fundraising, or sale discussions.

Failing to tie equity to contribution

Another common mistake is giving away large equity stakes before the work is done. In a specialist service business, commercial traction can take time. If one founder stops contributing but keeps their full stake, the remaining team may be stuck with a passive shareholder holding a blocking position.

Vesting, milestone-based equity, or buyback rights can help deal with that risk.

Not defining who can sign what

Founders sometimes assume authority based on job title. That can create problems if one founder signs a major service agreement, software licence, or recruitment contract without proper approval.

The agreement should make approval thresholds clear, especially for:

• high-value contracts
• borrowing or finance arrangements
• hiring senior personnel
• issuing new shares
• changing the business model

Ignoring privacy and sensitive information risks

Some founder documents treat confidentiality as a short boilerplate clause. That may be too light for a business handling trial-related information, site data, operational records, or potentially personal information.

If the business is building digital tools, check data access, data ownership, and privacy compliance early. Those issues should not be left to assumptions between founders.

Forgetting the exit plan

No founder wants to discuss departure at the start, but failing to do it is a classic mistake. If a founder leaves suddenly, the business needs a clear process for shares, handover, access to accounts, client communications, and confidential material.

Without that process, an operational setback can quickly become a legal dispute.

FAQs

Does every clinical trial service provider need a co-founder agreement?

Not every business is legally required to have one, but most founder teams should strongly consider it. If there is shared ownership, shared decision-making, or valuable IP involved, a written agreement is usually sensible.

Is a co-founder agreement the same as a shareholders agreement?

No. A co-founder agreement focuses on the founder relationship and early commercial arrangements. A shareholders agreement is usually a broader company-level document about shareholder rights, transfers, governance, and decision-making.

Can we just rely on our company constitution?

Usually not by itself. A constitution often does not deal in enough detail with founder roles, vesting, pre-existing IP, contribution expectations, confidentiality, or founder departure scenarios.

What if one founder already owns software or trial management tools?

The agreement should say clearly whether that asset is assigned to the company, licensed to it, or excluded from the business. Do not assume the company can freely use it without documenting the arrangement.

When should founders put the agreement in place?

Ideally, before you sign major contracts, before you spend money on setup, and before you rely on a verbal promise about equity or responsibilities. Early timing makes negotiation easier and reduces the chance of a later dispute.

Key Takeaways

• A co-founder agreement is not always mandatory in Australia, but it is usually a smart step for a clinical trial service provider with shared ownership, specialised know-how, or valuable business relationships.
• The agreement should cover equity, vesting, roles, authority, IP ownership, confidentiality, privacy expectations, restraints, and exit arrangements.
• Clinical trial service businesses face higher practical risk if software, SOPs, templates, sponsor information, or data rights are left unclear.
• Generic templates often miss the issues that matter most, especially around pre-existing IP, founder contributions, and who can sign key contracts.
• The best time to sort this out is before you sign, before you accept the provider's standard terms, and before you rely on verbal promises between founders.

If you want help with equity and vesting terms, IP ownership, confidentiality obligations, and founder exit arrangements, you can reach us on 1800 730 617 or team@sprintlaw.com.au for a free, no-obligations chat.